News Focus
News Focus
Post# of 257627
Next 10
Followers 64
Posts 11883
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 159087

Sunday, 03/31/2013 9:02:49 PM

Sunday, March 31, 2013 9:02:49 PM

Post# of 257627
Being that Sanofi and Biogen drug had ample time to evaluate the marketplace prior to approval their respective pricing could be anything but a coincidence.

BG-12's trial results coupled with its modest pricing premium puts it in a sweet spot.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today